PTK2 and neoplasm: Previous studies have shown that secreted ANGPTL4 interacts with integrin β1 and β5 on the cell surface, triggering downstream signaling pathways such as focal adhesion kinase (FAK) and proto-oncogene tyrosine-protein kinase SRC, thereby affecting tumor progression [38, 39].